Myrica ER Tablet 165 mg contains Pregabalin in an extended-release (ER) formulation, developed to provide consistent and long-lasting symptom control in patients suffering from neuropathic pain and related neurological conditions. The extended-release technology ensures gradual release of the active ingredient throughout the day, supporting stable blood levels and convenient once-daily dosing.
Pregabalin is widely prescribed for managing nerve-related pain and as adjunctive therapy in seizure disorders. Myrica ER 165 mg is particularly suitable for patients who require controlled and sustained relief with improved compliance.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Each extended-release tablet contains:
Pregabalin 165 mg
Pregabalin works by binding selectively to the alpha-2-delta subunit of voltage-gated calcium channels in the central nervous system. This action helps reduce the release of excitatory neurotransmitters such as glutamate, norepinephrine, and substance P. By stabilizing overactive nerve signals, it effectively decreases pain transmission and reduces seizure activity.
Myrica ER Tablet 165 mg is indicated for:
Neuropathic pain associated with diabetic peripheral neuropathy
Postherpetic neuralgia (nerve pain following shingles)
Neuropathic pain due to spinal cord injury
Fibromyalgia
Adjunctive treatment of partial-onset seizures in adults
The extended-release form provides continuous symptom control, making it beneficial for long-term management.
The dosage should be determined by a registered physician based on the patient’s condition, severity of symptoms, and kidney function. Myrica ER Tablet 165 mg is usually taken once daily after an evening meal.
The tablet must be swallowed whole with water. It should not be crushed, split, or chewed, as this may disrupt the extended-release system. Sudden discontinuation should be avoided; gradual dose reduction is recommended to prevent withdrawal symptoms such as insomnia, nausea, headache, or anxiety.
Dose adjustments may be necessary in patients with renal impairment.
Provides sustained and consistent pain relief
Convenient once-daily dosing
Helps reduce burning, tingling, and shooting nerve pain
Improves sleep disturbances associated with chronic pain
Enhances overall quality of life
Common side effects may include:
Dizziness
Drowsiness
Dry mouth
Blurred vision
Peripheral edema
Weight gain
Most adverse effects are mild to moderate and often decrease with continued use. Patients should consult a healthcare provider if side effects persist or become bothersome.
Use cautiously in patients with kidney disease.
May cause dizziness and sleepiness; avoid driving or operating machinery until effects are known.
Monitor for mood changes or signs of depression.
Use during pregnancy or breastfeeding only if clearly prescribed by a physician.
Store below 30°C in a dry place, protected from light and moisture. Keep out of reach of children.
Myrica ER Tablet 165 mg offers reliable and extended relief for neuropathic pain and seizure-related conditions, supporting better symptom control with simplified dosing.
Login Or Registerto submit your questions to seller
No none asked to seller yet